Table 3

Univariate area under receiver operating characteristic curve data for predicting various outcomes from baseline bloods

BiomarkerPatients
(N)
Cases
(N)
D.F.AUC
(95% CI)
30-day mortality
 MR-proADM1353010.8441 (0.7761 to 0.9122)
 CRP1353010.6132 (0.5066 to 0.7198)
 PCT1162610.6212 (0.4963 to 0.7460)
 Neutrophils1353010.5503 (0.4356 to 0.6650)
 Lymphocytes1353010.5629 (0.4373 to 0.6884)
Critical care admission
 MR-proADM1353110.594 (0.4873 to 0.7007)
 CRP1353110.7238 (0.6213 to 0.8263)
 PCT1163110.6856 (0.5771 to 0.7941)
 Neutrophils1353110.6158 (0.5104 to 0.7213)
 Lymphocytes1353110.5296 (0.4147 to 0.6446)
NIV
 MR-proADM1352310.7189 (0.617 to 0.8209)
 CRP1352310.722 (0.6068 to 0.8373)
 PCT1162210.7706 (0.6734 to 0.8677)
 Neutrophils1352310.5615 (0.4505 to 0.6726)
 Lymphocytes1352310.5646 (0.4476 to 0.6817)
Intubation and ventilation
 MR-proADM1351610.75 (0.6434 to 0.8566)
 CRP1351610.7545 (0.6059 to 0.903)
 PCT1161610.8497 (0.7565 to 0.9429)
 Neutrophils1351610.6476 (0.5104 to 0.7848)
 Lymphocytes1351610.468 (0.324 to 0.612)
  • AUC, area under the curve; CRP, C reactive protein; D.F., Degrees of Freedom; MR-proADM, mid-regional proadrenomedullin; NIV, non-invasive ventilation; PCT, procalcitonin.